PFG
EW icon

Putney Financial Group’s Edwards Lifesciences EW Stock Holding History

Putney Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24
Closed -$1.88K – 146
2025
Q2 		$1.88K Buy
+24
New +$1.79K ﹤0.01% 268

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Putney Financial Group's EW Position: Q3 2025 in Review

Putney Financial Group sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 24 shares — an estimated $1.88K sold.

Putney Financial Group first reported a position in EW in Q2 2025 and held it in 1 quarter. The position peaked at $1.88K in Q2 2025. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Putney Financial Group reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Putney Financial Group sold 24 Edwards Lifesciences shares in Q3 2025, an estimated $1.88K.
  • Putney Financial Group first reported a position in Edwards Lifesciences in Q2 2025 and held it in 1 quarter.
  • Putney Financial Group's Edwards Lifesciences position peaked at $1.88K in Q2 2025.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Putney Financial Group's 13F filing for Q3 2025, filed 7 Nov 2025.